FDA advisers back gene therapy for rare form of blindness

FDA advisers back gene therapy for rare form of blindness

Advisers to the US Food and Drug Administration (FDA) have paved the way for the agency’s first approval of a gene therapy to treat a disease caused by a genetic mutation.

Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Featured (sidebar) / FDA advisers back gene therapy for rare form of blindness